Literature DB >> 36051428

More studies are necessary to establish the effectiveness of Jinhuang powder in the treatment of diabetic foot.

Ya-Wen Ye1, Zi-Yun Yan1, Lian-Ping He1, Cui-Ping Li2.   

Abstract

Diabetes mellitus is a common global public health problem that can cause serious illness and premature death. Diabetic foot ulcer, one of the complications of diabetes, is a major cause of morbidity and mortality and is associated with many other devastating complications. Previous study found that a group of traditional Chinese medicine (TCM) can be used for treating diabetic foot ulcers. More and more attention is being paid to the use of Chinese medicine to heal diabetic feet. Under the guidance of relevant theories of traditional Chinese medicine, more studies are needed to reveal the key active components and related signal pathways of TCM in the treatment of diabetic foot ulcer. One clinical study explored the treatment of diabetic foot with infection combined moist exposed burn ointment with Jinhuang powder. However, large-scale multi-center, double blind, randomized, placebo-controlled clinical trials and animal studies are necessary to establish the effectiveness of Jinhuang powder in the treatment of diabetic foot. ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Diabetic foot; Jinhuang powder; Traditional Chinese medicine

Year:  2022        PMID: 36051428      PMCID: PMC9329839          DOI: 10.4239/wjd.v13.i7.581

Source DB:  PubMed          Journal:  World J Diabetes        ISSN: 1948-9358


Core Tip: In recent years, most diabetic foot patients in China are adopting traditional Chinese medicine and western medicine. The short duration of clinical follow-up was not sufficient to explain the efficacy of the treatment, and the safety of the treatment was not mentioned. Large multicenter, double-blind, randomized, placebo controlled clinical trials and animal studies are necessary to determine Jinhuang powder as supplement combined with other Chinese medicine or western medicine as an effective and safe therapy for diabetic foot.

TO THE EDITOR

This is a comment on “This is a comment on “Clinical Study of moist exposed burn ointment (MEBO) Combined with Jinhuang powder for Diabetic Foot with Infection”[1]. We were pleased that read the research article by Hong-Bo Zhan, et al[1]. Their work highlights that the use of Jinhuang powder as supplement combined with MEBO as an effective and safe therapy for diabetic foot. This study provides important clues to the treatment of foot infection, ulcer. Diabetic foot ulcers are one of the most challenging complications of diabetes[2-4]. Previous study found that a group of traditional Chinese medicine (TCM) (e.g., herbal medicine foot bath decoction[5], TCM injections[6,7], Chinese herbal medicine ulcer oil[8], moxibustion[9], Astragali Radix and Rehmanniae Radix Mixture[10], the peptide compounds of Wuguchong[11], Astragali Radix and Rehmanniae Radix[12,13]) played an important role in the treatment of the disease. Some study also found that interventional radiology plays a crucial role in the treatment of diabetic foot disease[14]. However, the study only focuses on Jinhuang powder has improved the efficacy and safety of MEBO in the treatment of diabetic foot. Thus, some questions still need further be discussed. In recent years, most diabetic foot patients in China are adopting TCM and western medicine[5,15]. A series of systematic review articles showed that TCM can increase the clinical effective rate of conventional therapies by 27%[6], regulate the signaling pathways to promote diabetic wound healing[16]. An experiment on albino Wistar rats found that Astragali Radix and Rehmanniae Radix in the ratio of 2:1 significantly enhance the circulating CD34+/VEGFR2+/CD45-EPCs levels in diabetic foot ulcer[17]. Another study confirmed the effect of the peptide compounds of Wuguchong in treating diabetic ulcers to a certain extent[11]. However, therapeutic effect criterion is observing wound surface and assessing degree of pain. The research evaluation index was single and lacked objective evaluation. Another problem of this study was research design. It was only a single-center trial, no double blindness, no placebo group. The short duration of clinical follow-up was not sufficient to explain the efficacy of the treatment, and the safety of the treatment was not mentioned. Large multicenter, double-blind, randomized, placebo controlled clinical trials and animal studies are necessary to determine Jinhuang powder as supplement combined with other Chinese medicine or western medicine as an effective and safe therapy for diabetic foot. Increasing attention is being given to the use of Chinese medicine for healing diabetic foot. Under the guidance of relevant theories of TCM, more studies are needed to reveal the key active components and related signal pathways of TCM in the treatment of diabetic foot ulcer, so as to promote the further research and clinical application of TCM[16]. Overall, MEBO combined with Jinhuang powder is more effective than MEBO alone in treating diabetic foot. However, large-scale multi-center, double blind, randomized, placebo-controlled clinical trials and animal studies are also necessary to establish the effectiveness of Jinhuang powder in the treatment of diabetic foot.
  17 in total

1.  Study on the action mechanism of the peptide compounds of Wuguchong on diabetic ulcers, based on UHPLC-Q-TOF-MS, network pharmacology and experimental validation.

Authors:  Pan Taowen; Fan Shuyuan; Shi Xiaoli; Wang Annan; Qiu Feng; Zhang Yizhong; Liu Jing; Li Bin; Li Kun; Diao Yunpeng
Journal:  J Ethnopharmacol       Date:  2022-01-13       Impact factor: 4.360

Review 2.  The signaling pathways of traditional Chinese medicine in promoting diabetic wound healing.

Authors:  Xin Zhou; Yanling Guo; Kun Yang; Peng Liu; Jun Wang
Journal:  J Ethnopharmacol       Date:  2021-09-20       Impact factor: 4.360

3.  Herbal formula Astragali Radix and Rehmanniae Radix exerted wound healing effect on human skin fibroblast cell line Hs27 via the activation of transformation growth factor (TGF-β) pathway and promoting extracellular matrix (ECM) deposition.

Authors:  Qi Zhang; Chi Chun Fong; Wai Kin Yu; Yao Chen; Fan Wei; Chi Man Koon; Kit Man Lau; Ping Chung Leung; Clara Bik San Lau; Kwok Pui Fung; Mengsu Yang
Journal:  Phytomedicine       Date:  2012-10-17       Impact factor: 5.340

4.  Evaluation of the key active ingredients of 'Radix Astragali and Rehmanniae Radix Mixture' and related signaling pathways involved in ameliorating diabetic foot ulcers from the perspective of TCM-related theories.

Authors:  Shuyuan Fan; Xiaoli Shi; Annan Wang; Tiejun Hou; Kun Li; Yunpeng Diao
Journal:  J Biomed Inform       Date:  2021-08-30       Impact factor: 6.317

Review 5.  Traditional Chinese Medicine Injections in the Treatment of Diabetic Foot: A Systematic Review and Meta-Analysis.

Authors:  Lizi Tan; Qingyang Shi; Chunxiang Liu; Junhua Zhang; Hui Wang; Jingbo Zhai
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-08       Impact factor: 2.629

6.  Chinese medicine ulcer oil promotes the healing of diabetic foot ulcers.

Authors:  Hui Jia; Bohua Yang; Youshan Li; Chen Liang; Haibin Lu; Dongyang Lin; Shang Ju
Journal:  J Int Med Res       Date:  2018-06-19       Impact factor: 1.671

Review 7.  Management of diabetic foot ulcers and the challenging points: An endocrine view.

Authors:  Hakan Doğruel; Mustafa Aydemir; Mustafa Kemal Balci
Journal:  World J Diabetes       Date:  2022-01-15

8.  Efficacy of moxibustion in diabetes peripheral neuropathy.

Authors:  Jing Sheng Tay; Yun Jin Kim
Journal:  Medicine (Baltimore)       Date:  2021-12-10       Impact factor: 1.817

9.  Clinical study for external washing by traditional Chinese medicine in the treatment of multiple infectious wounds of diabetic foot: Study protocol clinical trial (SPIRIT compliant).

Authors:  Yuan Zhang; Haipo Yuan; Jian Kang; Hongyan Xie; Xinhua Long; Luguang Qi; Chunguang Xie; Guangming Gong
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.